Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative
- 14 August 2010
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 30 (1) , 8-16
Abstract
This study showed that 13-chlorine-3,15-dioxy-gibberellic acid methyl ester (GA-13315), a gibberellin derivative, possessed high antitumor and antiangiogenic activity in vitro and in vivo. Cytotoxicity assays showed that GA-13315 was a potential and efficient antitumor compound, with inhibitory concentration 50 (IC50) values ranging from 0.13 to 30.28 μg/ml in 12 human tumor cell lines, and it showed moderate toxicity to peripheral blood mononuclear cells with an IC50 value of 14.2 μg/ml. Administration of 0.5 or 2.5 mg/kg GA-13315 for 23 days significantly inhibited tumor growth of human non-small cell lung tumor (A549) xenografts, with relative growth rates ranging from 29.91% to 35.05%. Acute toxicity was determined in ICR mice, and the lethal dose 50 (LD50) was 4.19 g/kg after intragastric administration. The high antitumor potency of GA-13315 occurred in parallel with its antiangiogenic activity. In vitro, GA-13315 inhibited recombinant human epithelial growth factor-induced chemotactic motility and capillary-like tube formation of primary cultured human endothelial cells. Furthermore, GA-13315 decreased the factor VIII+ microvessel density and vascular endothelial growth factor expression in A549 tumors, indicating its antiangiogenic efficacy in vivo. These results indicate that the antiangiogenic activity of GA-13315 contributes to its anticancer properties. Further studies are needed to investigate the use of GA-13315 as an anticancer drug.Keywords
This publication has 16 references indexed in Scilit:
- Synthesis of gibberellin derivatives with anti-tumor bioactivitiesBioorganic & Medicinal Chemistry Letters, 2009
- Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cellsEuropean Journal of Medicinal Chemistry, 2008
- Diterpenoids from Isodon species and their biological activitiesNatural Product Reports, 2006
- Regulation of Tumor Angiogenesis by Fastatin, the Fourth FAS1 Domain of βig-h3, via αvβ3 IntegrinCancer Research, 2005
- Matrix Metalloproteinase Inhibitor Development and the Remodeling of Drug DiscoveryHeart Failure Reviews, 2004
- Sphingosine 1-Phosphate Induces Angiogenesis: Its Angiogenic Action and Signaling Mechanism in Human Umbilical Vein Endothelial CellsBiochemical and Biophysical Research Communications, 1999
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transf erase-π in human lung tumorsCancer, 1992
- The chemistry of gibberellins: an overviewChemical Reviews, 1992
- Volkensin, the toxin of Adenia volkensii (kilyambiti plant)FEBS Letters, 1984